Evaluation of recombinase-based isothermal amplification assays for point-of-need detection of SARS-CoV-2 in resource-limited settings. (January 2022)
- Record Type:
- Journal Article
- Title:
- Evaluation of recombinase-based isothermal amplification assays for point-of-need detection of SARS-CoV-2 in resource-limited settings. (January 2022)
- Main Title:
- Evaluation of recombinase-based isothermal amplification assays for point-of-need detection of SARS-CoV-2 in resource-limited settings
- Authors:
- Ghosh, Prakash
Chowdhury, Rajashree
Hossain, Mohammad Enayet
Hossain, Faria
Miah, Mojnu
Rashid, Md. Utba
Baker, James
Rahman, Mohammed Ziaur
Rahman, Mustafizur
Ma, Xuejun
Duthie, Malcolm S.
Wahed, Ahmed Abd El
Mondal, Dinesh - Abstract:
- Highlights: Point-of-need diagnostics are required to contain the spread of SARS-CoV-2. Recombinase-based assays rapidly detect SARS-CoV-2 in clinical samples. The two isothermal amplification methods tested showed promising diagnostic efficiency. The incorporation of these techniques in a 'suitcase laboratory' may facilitate remote deployment. Abstract: Objectives: The democratization of diagnostics is one of the key challenges towards containing the transmission of coronavirus disease 2019 (COVID-19) around the globe. The operational complexities of existing PCR-based methods, including sample transfer to advanced central laboratories with expensive equipment, limit their use in resource-limited settings. However, with the advent of isothermal technologies, the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is possible at decentralized facilities. Methods: In this study, two recombinase-based isothermal techniques, reverse transcription recombinase polymerase amplification (RT-RPA) and reverse transcription recombinase-aided amplification (RT-RAA), were evaluated for the detection of SARS-CoV-2 in clinical samples. A total of 76 real-time reverse transcription PCR (real-time RT-PCR) confirmed COVID-19 cases and 100 negative controls were evaluated to determine the diagnostic performance of the isothermal methods. Results: This investigation revealed equally promising diagnostic accuracy of the two methods, with a sensitivity of 76.32% (95%Highlights: Point-of-need diagnostics are required to contain the spread of SARS-CoV-2. Recombinase-based assays rapidly detect SARS-CoV-2 in clinical samples. The two isothermal amplification methods tested showed promising diagnostic efficiency. The incorporation of these techniques in a 'suitcase laboratory' may facilitate remote deployment. Abstract: Objectives: The democratization of diagnostics is one of the key challenges towards containing the transmission of coronavirus disease 2019 (COVID-19) around the globe. The operational complexities of existing PCR-based methods, including sample transfer to advanced central laboratories with expensive equipment, limit their use in resource-limited settings. However, with the advent of isothermal technologies, the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is possible at decentralized facilities. Methods: In this study, two recombinase-based isothermal techniques, reverse transcription recombinase polymerase amplification (RT-RPA) and reverse transcription recombinase-aided amplification (RT-RAA), were evaluated for the detection of SARS-CoV-2 in clinical samples. A total of 76 real-time reverse transcription PCR (real-time RT-PCR) confirmed COVID-19 cases and 100 negative controls were evaluated to determine the diagnostic performance of the isothermal methods. Results: This investigation revealed equally promising diagnostic accuracy of the two methods, with a sensitivity of 76.32% (95% confidence interval 65.18–85.32%) when the target genes were RdRP and ORF1ab for RT-RPA and RT-RAA, respectively; the combination of N and RdRP in RT-RPA augmented the accuracy of the assay at a sensitivity of 85.53% (95% confidence interval 75.58–92.55%). Furthermore, high specificity was observed for each of the methods, ranging from 94.00% to 98.00% (95% confidence interval 87.40–9.76%). Conclusions: Considering the diagnostic accuracies, both RT-RPA and RT-RAA appear to be suitable assays for point-of-need deployment for the detection of the pathogen, understanding its epidemiology, case management, and curbing transmission. … (more)
- Is Part Of:
- International journal of infectious diseases. Volume 114(2022)
- Journal:
- International journal of infectious diseases
- Issue:
- Volume 114(2022)
- Issue Display:
- Volume 114, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 114
- Issue:
- 2022
- Issue Sort Value:
- 2022-0114-2022-0000
- Page Start:
- 105
- Page End:
- 111
- Publication Date:
- 2022-01
- Subjects:
- SARS-CoV-2 -- RT-RPA -- RT-RAA -- Recombinase -- Diagnosis -- Point-of-need
Communicable diseases -- Periodicals
Communicable Diseases -- Periodicals
Communicable diseases
Periodicals
Electronic journals
616.9 - Journal URLs:
- http://bibpurl.oclc.org/web/73769 ↗
http://www.journals.elsevier.com/international-journal-of-infectious-diseases/ ↗
http://www.sciencedirect.com/science/journal/12019712 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/12019712 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/12019712 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.ijid.2021.11.007 ↗
- Languages:
- English
- ISSNs:
- 1201-9712
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.304750
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 20428.xml